Riskpilot← Back to searchSign inGet full accessPro-Meduc Holding A/S
A/SActiveCVR 40566392Strandvejen 168Activities of holding companies · NACE 6421Est. 2019— employees
Revenue 2025
DKK -97K
-1% vs 2024
EBITDA margin
100.0%
+1% vs 2024
Equity ratio
92.9%
Financial strength
Net profit 2025
DKK 5,3M
+134% vs 2024
| Revenue | DKK -97K | -1% |
| EBITDA | DKK -97K | +1% |
| Net profit | DKK 5,3M | +134% |
| Total assets | DKK 81,9M | +8% |
| Equity | DKK 76M | +7% |
| Employees | — | — |
Legal name
Pro-Meduc Holding A/S
CVR number
40566392
Legal form
Aktieselskab
NACE code
6421 · Activities of holding companies
Founded
30. maj 2019
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsen i forening eller af direktionen og bestyrelsesformanden.
Company purpose
Selskabets formål er at eje aktier i Pro-Meduc A/S og dermed beslægtet virksomhed.
Address
Strandvejen 168
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -10 | -17 | -19 | -98 | -97 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | -17 | -19 | -98 | -97 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | -17 | -19 | -98 | -97 |
| Net financials | 10.768 | -2.431 | 1.680 | 2.335 | 5.314 |
| Profit before tax | 10.758 | -2.449 | 1.661 | 2.237 | 5.217 |
| Tax | -1 | -1 | -21 | -45 | -129 |
| Net profit | 10.759 | -2.447 | 1.682 | 2.282 | 5.346 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 75.158 | 70.838 | 73.141 | 75.629 | 81.852 |
| Equity | 70.559 | 67.648 | 69.090 | 71.120 | 76.037 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.599 | 3.191 | 4.051 | 4.509 | 5.815 |
| Total debt | 4.599 | 3.191 | 4.051 | 4.509 | 5.815 |
EBITDA margin
-9700000.0%
This company
15.8%
Market median
-61392505% vs market
20212025
Equity ratio
92.9%
This company
38.2%
Market median
+143% vs market
20212025
Return on equity
7.0%
This company
18.4%
Market median
-62% vs market
20212025
Net profit margin
534600000.0%
This company
8.1%
Market median
+6599999900% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CH Founder | Founder | 2019 |
TP Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 100% | 2025 | |
| Individual | 20–24.99% | 0% | 2019 | |
| Individual | 20–24.99% | 0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pro-Meduc Holding A/S 
PRO-MEDUC GROUP A/SBoard members of Pro-Meduc Holding A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Hellmann | Founder | 0 companies |
| Tine Pauline Sell Hellmann | Chief Executive Officer | 0 companies |
| Sanne Wall-Gremstrup | Chairman | 0 companies |